Alembic Pharmaceuticals Limited — Important, 31-05-2025: Updates
31-05-2025 | 11:13 pm
31-05-2025 | 11:13 pm
Alembic Pharmaceuticals’ API-I & II facility at Panelav completed a USFDA inspection with four observations, none related to data integrity. Management considers these issues manageable and will submit a detailed response. The company continues to prioritize high-quality standards and regulatory compliance.
No comments yet. Be the first to comment!
